Comments
Shares of pharmaceutical major Lupin Ltd recovered and ended the session higher by 9.04 per cent at Rs 1,801.45 on the BSE.
Earlier, the stock plunged 2.8 per cent ahead of October-December quarter earnings. The results were expected during market hours.
Analysts on average expect the company to post a net profit of Rs 530 crore ($78 million) on a revenue of Rs 3,360 core, says Thomson Reuters I/B/E/S/
Traders say yen’s volatility might impact the company’s Japan business, which contributes 11 per cent to the revenue ($1 = 67.6350 Indian rupees).
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.